Skin Carcinoma Clinical Trial
Official title:
Improving Sun-Protective Behaviors and Skin Self-Examinations Among African Americans
This randomized clinical trial uses an educational brochure and online tutorial program to assess sun-protective behavior and skin self-examination among African Americans. Skin cancer is very common among African Americans, with a disproportionately high mortality rate. Providing a brochure and an online educational program about sun-protective behaviors may encourage African Americans to take preventative measures against skin cancer, help improve early skin cancer detection, determine how far the disease has spread, and plan the best treatment.
Status | Completed |
Enrollment | 143 |
Est. completion date | September 2015 |
Est. primary completion date | September 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Self-identified African-Americans who are literate and fluent in English Exclusion Criteria: - Non-African-Americans - English illiteracy - non-fluency in English |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
United States | Case Comprehensive Cancer Center | Cleveland | Ohio |
Lead Sponsor | Collaborator |
---|---|
Case Comprehensive Cancer Center | National Cancer Institute (NCI) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in sunscreen use among African-American patients | Change in sun-protective behaviors among African-American patients. Measured by sunscreen use. All responses for questions about sun-protective behaviors are on a 5-point Likert scale. Summary scores will be created at baseline and short-term (1 month) follow-up for both control and treatment groups. The outcome variable is a continuous variable. Treatment scores individuals on the intervention group will be compared. T-tests will be used to compare mean scores for sun-protective behaviors between control and treatment groups. | Baseline to day 30 | No |
Primary | Change in apparel use when exposed to sun among African-American patients | Change in sun-protective behaviors among African-American patients. Measured by apparel use when exposed to sun. All responses for questions about sun-protective behaviors are on a 5-point Likert scale. Summary scores will be created at baseline and short-term (1 month) follow-up for both control and treatment groups. The outcome variable is a continuous variable. Treatment scores individuals on the intervention group will be compared. T-tests will be used to compare mean scores for sun-protective behaviors between control and treatment groups. | Baseline to day 30 | No |
Primary | Change in frequency of tanning among African-American patients | Change in sun-protective behaviors among African-American patients. Measured by frequency of tanning. All responses for questions about sun-protective behaviors are on a 5-point Likert scale. Summary scores will be created at baseline and short-term (1 month) follow-up for both control and treatment groups. The outcome variable is a continuous variable. Treatment scores individuals on the intervention group will be compared. T-tests will be used to compare mean scores for sun-protective behaviors between control and treatment groups. | Baseline to day 30 | No |
Secondary | Change in skin self-examinations among African-American patients as measured by knowledge, behavior and anxiety | Analyzed by looking at increase or decrease in skin self-examinations the patients report from pre-intervention to post-intervention. Performance of skin self-examination is measured by knowledge, behavior, and anxiety. Most responses for questions about skin self-examinations are on a 5-point Likert scale, while some are yes/no or true/false. Summary scores will be created at baseline and short-term (1 month) follow-up for both control and treatment groups. The outcome variable is a continuous variable. T-tests will be used to compare mean scores for skin self-examinations between groups. | Baseline to day 30 | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04358276 -
Technology-Enabled Activation of Skin Cancer Screening for Stem Cell Transplant Survivors and Their Primary Care Providers, TEACH Study
|
N/A | |
Completed |
NCT01242618 -
Tissue Engineered Nasal Cartilage for Reconstruction of the Alar Lobule
|
Phase 1 | |
Not yet recruiting |
NCT06167096 -
Effects of Lavender Aromatherapy on Patient Anxiety During Mohs Micrographic Surgery
|
N/A | |
Recruiting |
NCT03699995 -
MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma
|
N/A | |
Completed |
NCT04456140 -
Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study
|
Phase 1 | |
Terminated |
NCT03630601 -
Photoacoustic Imaging in Diagnosing Changes in Tumors in Participants With Breast Cancer, Sarcoma, Skin Cancer, or Soft Tissue Malignancy and Healthy Volunteers
|
N/A | |
Recruiting |
NCT03543969 -
Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma
|
Early Phase 1 | |
Completed |
NCT00783965 -
Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back
|
Phase 2 | |
Recruiting |
NCT04475640 -
Cancer Genetic Testing in Ethnic Populations
|
N/A | |
Active, not recruiting |
NCT02465060 -
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
|
Phase 2 | |
Completed |
NCT03177057 -
SMART Project in Preventing Skin Cancer
|
N/A | |
Completed |
NCT03290989 -
Itch and Pain Characteristics in Skin Carcinomas
|
N/A |